The Multiple Myeloma Research Foundation (MMRF) helps accelerate the development of next generation multiple myeloma treatments to extend patient’s lives, and lead to a cure. MMRF brings treatment to multiple myeloma patients 60% faster than the average through collaboration with best in class partners in the US and Internationally. In the process, we are changing the way cancer research is conducted. MMRF, a 501(c)(3), is the number one private funder of multiple myeloma research in the United States.
Press Release: MMRF & MMRC part of 4 abstracts for presentation at ASCO 2015. Learn more
Press Release: Kathy Giusti delivers the 214th Commencement Address to graduating class of UVM. Read more
Join Crawfish for Cancer's 3rd Annual Boston Crawfish Boil on June 6. Learn more and get tickets here
Connect with patients, engage with experts, get the information you need! MMRF CoMMunity Gateway
Tom Brokaw describes his battle with multiple myeloma in his memoir A Lucky Life Interrupted.
Tri-State 5K Walk/Run
Join us on June 7th
At the MMRF, we’re urgently working to develop treatments to extend your life. We can notify you about clinical trials, connect you to other patients with the same disease characteristics, bring you the latest breaking developments, and more. We’re learning every day. You can too.LEARN MORE
The model we have created for drug discovery and development is revolutionary. It brings multiple myeloma treatments to trial 60% faster than average. It has resulted in seven multiple myeloma drugs receiving FDA approval in the time it normally takes for one. Through the power of new technology, genomics and immunology, it has extended lives that would have been lost to multiple myeloma yesterday. And it is accelerating all the time. Learn how we are doing it.